Background and objectives: Hepatitis C virus (HCV) 
I. Introduction
Chronic liver diseases are mainly due to Hepatitis C virus, which further leads to cirrhosis of liver with increased risk of hepatocellular carcinoma. [1] Radiological testing, biochemical analysis and routine serological examination mostly discover chronic hepatitis C.
There are still many aspects to be discovered related to the natural history and progression of hepatitis C virus. The various factors that are important in predicting the outcome of disease progression include age of infection, genotype/subtype, gender of the patient, mode of infection and viral load. [2] Standard clinical and biochemical techniques help to monitor the rate progression from chronic hepatitis leading to cirrhosis and hepatocellular carcinoma. Histology is mainly used in assessing severity of the disease and its progression. [3] Polymerase chain reaction (PCR) advancement allows the identification and quantification of HCV RNA from serum but its clinical role remains unclear. A relationship can be drawn out between HCV type, subtype and serum HCV RNA levels. [4] The relationship between the biochemical markers of inflammation alanine transaminase (ALT) , serum HCV RNA levels by RT-PCR and histological degree of inflammation shows conflicting reports. [5] The reason behind this may be the heterogeneity of the patients studied, which includes ethnic origin, mixed age and gender, ill-defined duration of disease and mixed HCV genotypes and subtypes. AST is normally found in a diversity of tissues including liver, heart, muscle, kidney, and brain. It is released into serum when any one of these tissues is damaged. For example, its level in serum rises with heart attacks and with muscle disorders. It is therefore not a highly specific indicator of liver injury. ALT is a very specific and well defined indicator of liver status during chronic diseases because ALT is most concentrated in the liver and is released in the bloodstream. [6] In case of bilirubin on the other hand during cirrhosis and viral hepatitis the level of enzyme is reduced due deficiency in metabolism (e.g., reduced hepatocyte uptake, impaired conjugation of bilirubin, and reduced hepatocyte secretion of bilirubin). The present study is mainly based on the distribution pattern of HCV genotypes in patients with chronic hepatitis and is linked with their biochemical profile and viral load.
II.
Materials and Methods
Patients
The data was collected for 29 patients over the year 2010-2014 who was either admitted or was attended by Medica Superspecilality Hospital in Kolkata.
Inclusion criterion
Patients with high viral load whose genotyping was done.
RNA extraction
The blood samples in EDTA vials were collected. The artus HCV RG RT-PCR kit that constitutes of a ready-to-use system for the detection of HCV RNA was used. [7] 2.4 Quantitative analysis of RNA PCR on Rotor-Gene Q instruments was done. 30µl of Master mix was pipetted into each PCR tube and 20µl of eluted sample RNA was added to it. 20µl of the quantitation standards (HCV RG) as positive control and 20µl of water as negative control were taken in separate tubes. The Hold temperature at 50°C is kept for 30mins.If the Hold temperature is at 95°C then it is kept for 15mins Cycling (cycle repeats 50 times) at 95°C for 30secs, 50°C for 60secs and at 72°C for 30secs Reverse transcription of the RNA takes place by initial activation of the hot start enzyme. Then amplification of the cDNA takes place. The fluorescence sensitivity is adjusted and the run is done.
HCV genotype analysis
HCV Genotype Plus Real-TM is used which is a Real-Time PCR test for the determination of HCV-RNA genotypes 1a, 1b, 2, 3, 4, 5a and 6 in the human plasma. 0.2 µl ready to use PCR tubes are there were the extracted viral RNA can be added. [8] The kit consists of primers and probes conserved to 5' UTR region of HCV genome. Exogenous internal control RNA was used to check the extraction and amplification.
Total Bilirubin analysis
VITROS TBIL slide method and VITROS chemistry products calibrator kit 4 was used on VITROS 250/ VITROS 5.1/FS integrated system. The specimen was centrifuged after it had clotted to prevent hemolysis. The VITROS slides are dry, multilayered analytical elements coated on polyester supports. 10 µl of patient sample was deposited onto the slide and evenly distributed to all of the layers. The spreading layer contains the appropriate substrate and other components needed for the reaction [9] . Dyphylline 0.5 mg and 4-(Ncarboxymethylaminosulfonyl) Benzene diazonium hexafluorophosphate 57 μg were added to measure the total bilirubin at a absorption maxima of 540 and 460 nm. [10] 2.7 S.G.P.T analysis VITROS ALT slides method and VITROS chemistry products calibrator kit 3 was used. Unhaemolysed patients serum was diluted with 7% VITROS BSA and reanalyzed. [11] The results are multiplied by the dilution factor to obtain an estimate of the original sample's alanine aminotransferase activity. Lactate dehydrogenase 0.12 U, L-alanine 0.86 mg, sodium α-ketoglutarate 54 μg, nicotinamide adenine dinucleotide( reduced )35 μg; and sodium pyridoxal-5-phosphate 11 μg are the reagents added to the 11µl patients sample . [12] .The rate of oxidation of NADH was monitored by reflectance spectrophotometry at 340 nm .The rate of change in reflection density is proportional to enzyme activity.
S.G.O.T analysis
VITROS AST slides method and VITROS chemistry products calibrator kit 3 was used. Unhaemolysed patients serum was diluted with 7% VITROS BSA and reanalyzed. [13] The results are multiplied by the dilution factor to obtain an estimate of the original sample's amino aminotransferase activity. Other than the main reagents enzyme cofactors, pigment, binders, buffer, surfactants, stabilizer, scavenger, dye solubilizer, filter dyes and cross-linking agents are used. [14] . The rate of oxidation of the leuco dye was monitored by reflectance spectrophotometry at 670 nm..
Total protein analysis
The VITROS TP Slide method is performed using the VITROS TP Slides and the VITROS Chemistry Products Calibrator Kit 4 on VITROS 250/ VITROS 5.1/FS integrated system. The specimen should be centrifuged and the patients serum should be separated from the cell material. [15] Copper sulfate 0.9 mg; tartaric acid 1.2 mg; and lithium hydroxide 1.3 mg are mixed with 10 µl of sample. [16] The other reagents used are polymer beads, binders and surfactants. The VITROS TP Slide is a multilayered, analytical element coated on a polyester support. The method of analysis is based on the biuret reaction, [17] which produces a violet complex when protein reacts with cupric ion (Cu+2) in an alkaline medium.
Alkaline phosphatase analysis
The VITROS ALKP Slide method is performed using the VITROS ALKP Slides and the VITROS Chemistry Products Calibrator Kit 3 on VITROS 250/ VITROS 5.1/FS integrated system. Unhaemolysed patient's serum is used. The specimen needs to be centrifuged and the serum has to be separated from the cell materials. p-nitrophenyl phosphate 55 µg; 2-amino-2-methyl-1-propanol (AMP) 0.1 mg; and magnesium sulfate 1.6 µg are mixed with 11 µl of sample. [18] The mixture is monitored by reflectance spectrophotometry at 400 nm.
III. Result
From Fig 1 it is evident that the number of indivisuals getting affected by genotype 1 is much more. The relation between HCV genotypes and serum glutamic pyruvic transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), total protein, total bilrubin, and alkaline phosphatase was studied None of these biochemical parameters except SGOT showed significant difference between the mean and standard deviation in genotype one. The difference between the others genotype were not well understood and need further mathematical analysis. 
IV. Discussion
Hepatitis С virus (HCV) is RNA-containing, hepatotropic virus belonging to the Flaviviridae family. Contamination with hepatitis С virus occurs at direct entering of the virus in blood (at parenteral interventions or during blood transfusions). Most people with acute HCV infection are asymptomatic or have mild symptoms (fatigue, nausea, jaundice) but they are unable to clear the virus and in approximately 80% of cases this leads to chronic infection. In 15 to 20% of patients chronic HCV infection progresses at a variable rate to cirrhosis, with a 1 to 4% annual risk of developing hepatocellular carcinoma. [8] HCV is transmitted primarily through the parenteral route and source of infection include injection, drug abuse, needle stick accidents and transfusion of blood and its bi-products. Dentists practicing oral surgery, practitioners of folk medicine and those involved in hairdressing and tattooing are also at higher risk for HCV. [19] Infections in North America, Latin America and Europe are mainly due to genotype 1. [20] North Africa and middle east have high prevalence of G4.the Asia pacific region is predominantly infected by genotype one followed by genotype 3. [20] Genotype two is present in most developed countries [21] [19] , but is less common than genotype 1. In this study however genotype 1 was found to be dominant in Kolkata and its surrounding areas (53.57%) followed by genotype 3(24.13%) and other than genotype 1, 2, 3, 4 (20.68%).
Viral load did not affect the liver enzymes SGOT and SGPT as shown in Fig 9 and 10 . Even though the viral load fluctuated amongst individuals the value of enzymes did not fluctuate accordingly. Even for high viral loads the amount of enzymes remained approximately similar. From Fig 2 in case of patient eleven we can see that even if the SGOT level was the highest the viral load was low (Fig 8) . There appears to be no significant correlation between HCV RNA levels and ALT values or histological activity in patients untreated by anti-viral therapies (Interferon). Viral load varies between infected individuals but is not a useful prognostic indicator nor does it measure the severity of virus-induced liver disease. [22] An initial step in detecting liver damage is a simple blood test to determine the presence of certain liver enzymes in the blood. Under normal circumstances, these enzymes reside within the cells of the liver. But when the liver is injured, these enzymes are spilled into the blood stream. Among the most sensitive and widely used of these liver enzymes are the aminotransferases. They include aspartate aminotransferase (AST or SGOT) and alanine aminotransferase (ALT or SGPT). These enzymes are normally contained within liver cells. If the liver is injured, the liver cells spill the enzymes into blood, raising the enzyme levels in the blood and signaling the liver damage. AST (SGOT) is normally found in a diversity of tissues including liver, heart, muscle, kidney, and brain. It is released into serum when any one of these tissues is damaged. For example, its level in serum rises with heart attacks and with muscle disorders. It is therefore not a highly specific indicator of liver injury. ALT (SGPT) is, by contrast, normally found largely in the liver. This is not to say that it is exclusively located in liver but that is where it is most concentrated. It is released into the bloodstream as the result of liver injury. It therefore serves as a fairly specific indicator of liver status. In this study SGOT was significantly different according to its standard deviation and mean in genotype 1 ( deranged but changes remained non significant as also reported earlier [23] .
V. Conclusion
Liver infections due to HCV genotype 1 was most prevalent in Kolkata and the surrounding areas followed by genotype 3. Care should be taken to prevent infections by HCV genotype 1 without ignoring genotype 3 and other prevailing genotypes.
